The Pharmacological Burden of Comorbidities in Acromegaly

Background: Acromegaly is characterized by excess GH and elevated IGF-I often treated by surgery, pharmacotherapy (somatostatin analogs, GH receptor antagonists, dopamine agonists) and/or radiotherapy.(1) Common associated comorbidities include cardiovascular disorders and hypopituitarism, often req...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Endocr Soc
Egile Nagusiak: Fleseriu, Maria, Barkan, Ariel, Schneider, Maria del Pilar, Darhi, Yannis, de Pierrefeu, Amicie, Munoz, Kathryn, Ribeiro-Oliveira, Antonio, Melmed, Shlomo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2021
Gaiak:
Neuroendocrinology and Pituitary
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090600/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.1324
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak